Trial intelligence / Profile preview

Ketamine vs Remifentanil on Renal Function in CABG Surgery

NCT02113150Phase 4Completed

Sponsor
Türkiye Yüksek İhtisas Eğitim ve Araştırma Hastanesi
Start
May 2013
Primary completion
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ketamine in coronary artery disease (CAD), sponsored by Türkiye Yüksek İhtisas Eğitim ve Araştırma Hastanesi. Started May 2013; status: completed.

02

Drugs

ketamine
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT02113150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02113150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call